Dergi makalesi Açık Erişim
<?xml version='1.0' encoding='UTF-8'?> <record xmlns="http://www.loc.gov/MARC21/slim"> <leader>00000nam##2200000uu#4500</leader> <controlfield tag="001">228066</controlfield> <datafield tag="540" ind1=" " ind2=" "> <subfield code="a">Creative Commons Attribution-NonCommercial</subfield> <subfield code="u">https://creativecommons.org/licenses/by-nc/4.0/</subfield> </datafield> <datafield tag="773" ind1=" " ind2=" "> <subfield code="i">isVersionOf</subfield> <subfield code="a">10.48623/aperta.228065</subfield> <subfield code="n">doi</subfield> </datafield> <datafield tag="909" ind1="C" ind2="4"> <subfield code="v">36</subfield> <subfield code="p">System Dynamics Review</subfield> <subfield code="n">3</subfield> <subfield code="c">294-329</subfield> </datafield> <controlfield tag="005">20211126154354.0</controlfield> <datafield tag="520" ind1=" " ind2=" "> <subfield code="a"><p>Tests to screen for certain diseases&mdash;for example, thyroid cancer screening, screening mammography,<br> and screening of high blood pressure for hypertension&mdash;are increasingly common in<br> medical practice. However, guidelines for routine screening are contentious for many disorders<br> and often fluctuate over time. Some tests are over- or underused compared to available evidence<br> that justifies their use, with clinical practice persistently deviating from evidence-based guidelines.<br> Here we develop an integrated, broad boundary feedback theory and formal model to<br> explain the dynamics of routine population screening including fluctuations in policy-decision<br> thresholds and the expansion of selection criteria which may lead to inappropriate use. We present<br> a behaviorally realistic, boundedly rational model of detection and selection for medical<br> screening that explains the potential of endogenous oscillations in practice guidelines as<br> decision-makers&mdash;including epidemiologists, clinicians, and patients, or policymakers from<br> guideline issuing organizations, perceive harms and benefits from potential outcomes and make<br> trade-offs between sensitivity and specificity by altering the existing guidelines and actual practice.<br> The model endogenously generates fluctuations in screening indications, test thresholds,<br> test efficiency, and the target screening population, leading to long periods during which practice<br> guidelines are suboptimal even if the underlying evidence base is constant. We use cancer<br> screening as a motivating example, but the model is generic with a wide range of potential applications<br> for important managerial problems in medical contexts, such as screening for hypertension,<br> hypercholesterolemia, autism spectrum disorder, Alzheimer&rsquo;s disease, and related<br> dementia. It also applies to other managerial problems in nonmedical contexts, such as airport<br> screening, background checks, tax audits, automotive emission tests, contentious jurisdiction, or<br> to consumers of other kinds of information who need to make a decision&mdash;on behalf of an individual,<br> or for the whole population.</p></subfield> </datafield> <datafield tag="245" ind1=" " ind2=" "> <subfield code="a">"Saving lives or harming the healthy?" Overuse and fluctuations in routine medical screening</subfield> </datafield> <datafield tag="041" ind1=" " ind2=" "> <subfield code="a">eng</subfield> </datafield> <datafield tag="909" ind1="C" ind2="O"> <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield> <subfield code="o">oai:zenodo.org:228066</subfield> </datafield> <datafield tag="542" ind1=" " ind2=" "> <subfield code="l">open</subfield> </datafield> <datafield tag="980" ind1=" " ind2=" "> <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield> </datafield> <datafield tag="856" ind1="4" ind2=" "> <subfield code="z">md5:71e0c5e0f6d045bb1554ec9fecaae684</subfield> <subfield code="s">1686925</subfield> <subfield code="u">https://aperta.ulakbim.gov.trrecord/228066/files/Karanfil_Sterman Medical Screening SDR2020.pdf</subfield> </datafield> <datafield tag="024" ind1=" " ind2=" "> <subfield code="2">doi</subfield> <subfield code="a">10.48623/aperta.228066</subfield> </datafield> <datafield tag="500" ind1=" " ind2=" "> <subfield code="a">Bu akademik calisma BIDEB- 2232 programi tarafindan desteklenmistir. Proje No: 118C327.</subfield> </datafield> <datafield tag="700" ind1=" " ind2=" "> <subfield code="0">(orcid)0000-0001-7476-6760</subfield> <subfield code="u">Massachusetts Institute of Technology</subfield> <subfield code="a">Sterman, John</subfield> </datafield> <datafield tag="650" ind1="1" ind2="7"> <subfield code="a">cc-by</subfield> <subfield code="2">opendefinition.org</subfield> </datafield> <datafield tag="980" ind1=" " ind2=" "> <subfield code="a">publication</subfield> <subfield code="b">article</subfield> </datafield> <datafield tag="260" ind1=" " ind2=" "> <subfield code="c">2020-10-06</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">evidence-based guidelines</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">system dynamics</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">clinical practice guidelines</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">health policy</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">cancer screening</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">population screening</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">medical screening</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">policy analysis</subfield> </datafield> <datafield tag="100" ind1=" " ind2=" "> <subfield code="0">(orcid)0000-0002-2319-0818</subfield> <subfield code="u">Koc Universitesi</subfield> <subfield code="a">Karanfil, Ozge</subfield> </datafield> </record>
Tüm sürümler | Bu sürüm | |
---|---|---|
Görüntülenme | 62 | 61 |
İndirme | 71 | 71 |
Veri hacmi | 119.8 MB | 119.8 MB |
Tekil görüntülenme | 50 | 49 |
Tekil indirme | 64 | 64 |